Wikipedia / open kennis

Canocapavir

Canocapavir is an investigational new drug that is being evaluated by Zhimeng Biopharma for the treatment of Hepatitis B infections. It is an HBV capsid assembly…

Canocapavir is an investigational new drug that is being evaluated by Zhimeng Biopharma for the treatment of Hepatitis B infections. It is an HBV capsid assembly inhibitor.

Clinical trials

Phase 3 clinical trials of canocapavir for the treatment of chronic HBV infections are planned.

Bron en licentie

Gebaseerd op: Wikipedia — Canocapavir · auteursgeschiedenis.

Tekst: CC BY-SA 4.0.

Over de bewerking

Wikisyntaxis en sjablonen zijn verwijderd; langere teksten zijn ingekort.